These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 6753611)
1. Enhancement of memory processes in Alzheimer's disease with multiple-dose intravenous physostigmine. Davis KL; Mohs RC Am J Psychiatry; 1982 Nov; 139(11):1421-4. PubMed ID: 6753611 [TBL] [Abstract][Full Text] [Related]
2. Oral physostigmine treatment for patients with presenile and senile dementia of the Alzheimer's type: a double-blind placebo-controlled trial. Jenike MA; Albert MS; Heller H; Gunther J; Goff D J Clin Psychiatry; 1990 Jan; 51(1):3-7. PubMed ID: 2403997 [TBL] [Abstract][Full Text] [Related]
3. Oral physostigmine and lecithin improve memory in Alzheimer disease. Thal LJ; Fuld PA; Masur DM; Sharpless NS Ann Neurol; 1983 May; 13(5):491-6. PubMed ID: 6347034 [TBL] [Abstract][Full Text] [Related]
4. Efficacy of oral physostigmine in primary degenerative dementia. A double-blind study of response to different dose level. Beller SA; Overall JE; Swann AC Psychopharmacology (Berl); 1985; 87(2):147-51. PubMed ID: 3931138 [TBL] [Abstract][Full Text] [Related]
5. Memory enhancement with oral physostigmine in Alzheimer's disease. N Engl J Med; 1983 Mar; 308(12):720-1. PubMed ID: 6338388 [No Abstract] [Full Text] [Related]
6. Physostigmine effects in Alzheimer's disease: relationship to dementia severity. Schwartz AS; Kohlstaedt EV Life Sci; 1986 Mar; 38(11):1021-8. PubMed ID: 3512944 [TBL] [Abstract][Full Text] [Related]
18. A signal detectability analysis of the effect of physostigmine on memory in patients with Alzheimer's disease. Mohs RC; Davis KL Neurobiol Aging; 1982; 3(2):105-10. PubMed ID: 6752738 [TBL] [Abstract][Full Text] [Related]
19. No effect from double-blind trial of physostigmine and lecithin in Alzheimer disease. Wettstein A Ann Neurol; 1983 Feb; 13(2):210-2. PubMed ID: 6830183 [TBL] [Abstract][Full Text] [Related]
20. Long-term administration of oral physostigmine in Alzheimer's disease. Stern Y; Sano M; Mayeux R Neurology; 1988 Dec; 38(12):1837-41. PubMed ID: 3057398 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]